Lung cancer genes linked to blood clot danger in new study
NCT ID NCT07288632
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study looks at whether certain gene changes in advanced lung cancer increase the risk of dangerous blood clots. Researchers will follow 500 people with stage III or IV non-small-cell lung cancer for 6 months, measuring blood markers and tracking clot events. The goal is to learn if a person's genetic profile could help predict and prevent clots in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emily Oliovecchio
RECRUITINGPerugia, Perugia, 06135, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.